Fate Therapeutics (FATE) names Matthew Abernethy to Board
Go back to Fate Therapeutics (FATE) names Matthew Abernethy to Board| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.73 | 52 Week High | $4.76 | |||
| Open | $2.73 | 52 Week Low | $1.46 | |||
| Day High | $2.73 | P/E | N/A | |||
| Day Low | $2.73 | EPS | $-1.91 | |||
| Volume | 172 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 171.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $171.55 | 52 Week High | $58.46 | |||
| Open | $171.55 | 52 Week Low | $31.25 | |||
| Day High | $171.55 | P/E | N/A | |||
| Day Low | $171.55 | EPS | $-0.69 | |||
| Volume | 50 | |||||
